DrugPatentWatch Database Preview
VANDAZOLE Drug Profile
Email this page to a colleague
» See Plans and PricingWhich patents cover Vandazole, and what generic alternatives are available?
Vandazole is a drug marketed by Teva Pharms and is included in one NDA. There is one patent protecting this drug.
The generic ingredient in VANDAZOLE is metronidazole. There are eighteen drug master file entries for this compound. Fifty-nine suppliers are listed for this compound. Additional details are available on the metronidazole profile page.
US ANDA Litigation and Generic Entry Outlook for Vandazole
A generic version of VANDAZOLE was approved as metronidazole by TEVA PHARMS USA on November 6th, 1984.
Summary for VANDAZOLE
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 143 |
| Patent Applications: | 4,160 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for VANDAZOLE |
| Drug Sales Revenues: | Drug sales revenues for VANDAZOLE |
| DailyMed Link: | VANDAZOLE at DailyMed |
Pharmacology for VANDAZOLE
| Drug Class | Nitroimidazole Antimicrobial |
US Patents and Regulatory Information for VANDAZOLE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Pharms | VANDAZOLE | metronidazole | GEL;VAGINAL | 021806-001 | May 20, 2005 | BX | RX | No | No | Start Trial | Start Trial | Y | Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Premature patent expiration for: VANDAZOLE
Expiration due to failure to pay maintenance fee
| Patent Number | Tradename | Expiration Date |
|---|---|---|
| Start Trial | VANDAZOLE | Start Trial |
